New wound treatment shows promise for diabetic foot ulcers

NCT ID NCT06511596

Completed Disease control Sponsor: BioStem Technologies Source: ClinicalTrials.gov ↗

First seen Jan 29, 2026 · Last updated May 11, 2026 · Updated 15 times

Summary

This study tested a product called BR-AC, made from donated birth tissue, for treating diabetic foot ulcers. 71 adults with diabetes and hard-to-heal foot sores were split into two groups: one got standard wound care plus BR-AC, the other got standard care alone. The goal was to see if BR-AC helps wounds close completely within 12 weeks. People who didn't heal with standard care could later try BR-AC.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Site 01

Vista, California, 92081, United States
Site 02

San Francisco, California, 94115, United States
Site 03

Fort Worth, Texas, 76104, United States
Site 04

Sylmar, California, 91342, United States
Site 05

McAllen, Texas, 78501, United States
Site 06

O'Fallon, Illinois, 62269, United States
Site 07

Torrance, California, 90502, United States
Site 08

North Chicago, Illinois, 60064, United States
Site 09

Frisco, Texas, 75034, United States
Site 10

Westwood, New Jersey, 07675, United States
Site 11

Miami, Florida, 33175, United States

Conditions

Explore the condition pages connected to this study.

DIABETIC FOOT ULCER